
Growth-hormone secretagogue research peptide for controlled laboratory studies.
- Dose
- 10 mg
- Batch
- 268012
CJC-1295 (No DAC)
[D-Ala2, Gln8, Ala15, Leu27]-human growth hormone-releasing factor (1-29) amide (tetrasubstituted hGRF(1-29)-NH2; Modified GRF 1-29)
For research purposes only — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Growth-hormone secretagogue research peptide for controlled laboratory studies.
Members get 10% off every order, on top of volume pricing — become a member with a free account.
Volume savings are applied automatically at checkout. Larger orders: support@alptide.ch
- Lab
- Janoshik Analytical
- Methods
- HPLC · LC-MS
For laboratory research use only. Not for human consumption.
Technical specifications
- Type
- Peptide
- Scientific name
- [D-Ala2, Gln8, Ala15, Leu27]-human growth hormone-releasing factor (1-29) amide (tetrasubstituted hGRF(1-29)-NH2; Modified GRF 1-29)
- Amino acids
- 29
- Sequence
- YADAIFTQSYRKVLAQLSARKLLQDILSR
- Molecular weight
- 3367.9 g/mol
- Formula
- C152H252N44O42
- Origin
- Synthetic analog of human GHRH(1-29) bearing four substitutions (D-Ala2, Gln8, Ala15, Leu27) and a C-terminal amide — the CJC-1295 peptide backbone without the maleimidopropionyl-Lys30 drug-affinity complex. Note: residue 2 is D-alanine, which the one-letter sequence cannot express.
- Lyophilized (powder)
- -20°C · stable long-term; keep sealed, desiccated and protected from light
- Reconstituted
- 2-8°C · use within 30 days; aliquot to avoid repeated freeze-thaw cycles
- Room temperature
- Lyophilized powder tolerates short ambient excursions in transit, but the peptide is hygroscopic and prolonged ambient storage promotes moisture uptake and aggregation. In solution at room temperature it degrades by hydrolysis within days and should not be held beyond 24 hours.
Peer-reviewed research
Published research and registered trials involving this compound. Provided for educational reference only — none of it is a claim about this product.
- EndocrinologyHuman growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analogJetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP2005DOI: 10.1210/en.2004-1286PMID: 15817669
- PeptidesGrowth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal menBarron JL, Coy DH, Millar RP1985DOI: 10.1016/0196-9781(85)90124-xPMID: 2866496
- Journal of Clinical Endocrinology & MetabolismIncorporation of D-Ala2 in growth hormone-releasing hormone-(1-29)-NH2 increases the half-life and decreases metabolic clearance in normal menSoule S, King JA, Millar RP1994DOI: 10.1210/jcem.79.4.7962295PMID: 7962295
- Journal of Clinical Endocrinology & MetabolismProlonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsTeichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA2006DOI: 10.1210/jc.2005-1536PMID: 16352683
- Journal of Clinical Endocrinology & MetabolismPulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analogIonescu M, Frohman LA2006DOI: 10.1210/jc.2006-1702PMID: 17018654
- American Journal of Physiology - Endocrinology and MetabolismOnce-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouseAlba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R2006DOI: 10.1152/ajpendo.00201.2006PMID: 16822960
- Growth Hormone and IGF ResearchActivation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjectsSackmann-Sala L, Ding J, Frohman LA, Kopchick JJ2009DOI: 10.1016/j.ghir.2009.03.001PMID: 19386527
- Drug Testing and AnalysisA method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MSTimms M, Ganio K, Steel R2019DOI: 10.1002/dta.2599PMID: 30938069
Researcher reviews
“99%+ is not marketing here — the LC-MS trace is on the product page. Rare to see a supplier publish the actual chromatogram.”
More in GH Secretagogues

Tesamorelin
10 mg / vial
Growth-hormone-releasing-hormone analogue for controlled laboratory research.

Ipamorelin
10 mg / vial
Growth-hormone secretagogue research peptide for controlled laboratory studies.